Health Benefits of Expressive Writing Among Chinese Breast Cancer Survivors
Reducing Psychological Burdens Among Chinese Breast Cancer Survivors
調査の概要
詳細な説明
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
California
-
Los Angeles、California、アメリカ、91776
- Herald Cancer Association
-
-
Texas
-
Houston、Texas、アメリカ、77204
- University of Houston
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
1) having a breast cancer diagnosis; 2) completing breast cancer surgery within five years; and 3) being comfortable writing and speaking Chinese (i.e. Mandarin or Cantonese)
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：支持療法
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：トリプル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
介入なし：制御条件
対照群の参加者は、自分のがんとその治療に関する事実について3週間にわたって3回のセッションで書くよう求められた。
|
|
|
実験的：Self-regulation condition
For the self-regulation condition, each weekly writing assignment covers a different task.
During session one, participants will be asked to write about their deepest feelings and thoughts regarding their experience with breast cancer as well as its impact on their lives; in session two, participants will be asked to write about their coping strategies to deal with stressors associated with the cancer diagnosis and treatment, as well as future plans for coping with cancer-related stressors; and in session three, participants will be asked to write about positive thoughts and feelings regarding their experience with breast cancer.
|
|
|
実験的：Enhanced self-regulation condition
For the enhanced self-regulation condition, each weekly writing assignment covers a different task.
During session one, participants will be asked to write about their coping strategies to deal with stressors associated with the cancer diagnosis and treatment, as well as future plans for coping with cancer-related stressors; during session two, participants will be asked to write about their deepest feelings and thoughts regarding their experience with breast cancer as well as its impact on their lives; and in session three, participants will be asked to write about positive thoughts and feelings regarding their experience with breast cancer.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in quality of life score as assessed by the Functional Assessment of Cancer Therapy Scale (FACT)
時間枠：Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.
|
The Functional Assessment of Cancer Therapy Scale (FACT) is a 27-item measure of health-related quality of life (Cella & Tulsky,1993), which assesses perceived life quality in four different facets, including physical well-being (7 items,score range 0 - 28), social well-being (7 items, score range 0 - 28), emotional well-being (6 items, score range 0-24), and functional well-being (7 items, score range 0-28). A higher subscale score indicates better functioning in the corresponding domain. Total score is computed by summing up the scores of the four subscales. Total score ranges from 0 to 108. A higher score indicates better quality of life. |
Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in posttraumatic stress disorder (PTSD), as assessed by the PTSD Symptom Scale - Self Report version (PSS-SR)
時間枠：Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.
|
The scale contains 17 items reflecting the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition -Text Revision (DSM-IV-TR) symptoms of post-traumatic stress disorder (Foa, Riggs, Dancu, & Rothbaum, 1993). Score can be reported in terms of total score or the score of the three subscales (Re-experiencing, Avoidance and Hyperarousal). The score ranges for the three sub-scales are: Re-experiencing symptoms (5 items, 0-15), Avoidance symptoms (7 items, 0 -21) and Hyperarousal symptoms (5 items, 0-15). Each subscale score is computed by summing up the scores of the corresponding items. For each subscale, a higher score indicates more severe symptoms. The total score is computed by summing up the scores of the three subscales. The total score ranges from 0 to 51. A higher score indicated more severe PTSD symptoms. |
Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.
|
|
Change in fatigue as assessed by Functional Assessment of Chronic Illness Therapy-Fatigue Scale (FACIT-F)
時間枠：Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.
|
The scale contains 13 items.
Total score is computed by summing up the scores of all the 13 items.
The total score ranges from 0 to 52.
A higher score indicates more severe fatigue symptoms.
|
Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.
|
|
Change in depressive symptoms as assessed by Center for Epidemiologic Studies Depression Scale (CES-D).
時間枠：Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.
|
The scale contains 10 items.
Total score is computed by summing up the scores of all the 10 items.
Total score ranges from 0 to 30.
A higher scores indicates more severe depression symptoms.
|
Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.
|
|
Change in anxiety as assessed by Brief Symptom Inventory (BSI)-anxiety dimension
時間枠：Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.
|
The scale contains 6 items.
Total score is computed by summing up the scores of all the 6 items.
Total score ranges from 0 - 24.
A higher score indicates more severe anxiety symptoms.
|
Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.
|
|
Change in physical symptoms as assessed by the Physical Symptoms Checklist
時間枠：Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.
|
The scale contains 10 items.
Total score is computed by summing up the scores of all the 10 items.
Total score ranges from 0 - 300.
A higher score indicates more severe physical symptoms.
|
Baseline, 1 month, 3 months, and 6 months follow-ups after the intervention.
|
協力者と研究者
スポンサー
捜査官
- 主任研究者：Qian Lu, Ph.D., MD、University of Houston
出版物と役立つリンク
一般刊行物
- Chu Q, Wu IHC, Tang M, Tsoh J, Lu Q. Temporal relationship of posttraumatic stress disorder symptom clusters during and after an expressive writing intervention for Chinese American breast cancer survivors. J Psychosom Res. 2020 Aug;135:110142. doi: 10.1016/j.jpsychores.2020.110142. Epub 2020 May 16.
- Chu Q, Wu IHC, Lu Q. Expressive writing intervention for posttraumatic stress disorder among Chinese American breast cancer survivors: the moderating role of social constraints. Qual Life Res. 2020 Apr;29(4):891-899. doi: 10.1007/s11136-019-02385-5. Epub 2020 Jan 3.
- Lu Q, Gallagher MW, Loh A, Young L. Expressive Writing Intervention Improves Quality of Life Among Chinese-American Breast Cancer Survivors: A Randomized Controlled Trial. Ann Behav Med. 2018 Oct 22;52(11):952-962. doi: 10.1093/abm/kax067.
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。